# 2025-11911: FDA starts planning five-year medical device fee renewal

2025-11911, Medical Device User Fee Amendments; Stakeholder Meetings on the Medical Device User Fee Amendments of Fiscal Years 2028 to 2032 Reauthorization; Request for Notification of Stakeholder Intention To Participate, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2025-06-27, effective Submit notification of intention to participate in these series of meetings on or before July 28, 2025. Stakeholder meetings will be held monthly. It is anticipated that they will commence by October 2025. A public meeting will be held on August 4, 2025. The current MDUFA V authorization expires September 30, 2027. (as of 2026-11-05).

- Canonical: https://policyrisk.com/federal-register/2025-11911
- As of: 2026-11-05
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-11911
- Title: Medical Device User Fee Amendments; Stakeholder Meetings on the Medical Device User Fee Amendments of Fiscal Years 2028 to 2032 Reauthorization; Request for Notification of Stakeholder Intention To Participate
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 27638
- Published: 2025-06-27
- Effective: Submit notification of intention to participate in these series of meetings on or before July 28, 2025. Stakeholder meetings will be held monthly. It is anticipated that they will commence by October 2025. A public meeting will be held on August 4, 2025. The current MDUFA V authorization expires September 30, 2027.
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-11-05

## In one line

FDA starts planning five-year medical device fee renewal

## Summary

The FDA is gearing up to renew the Medical Device User Fee program for 2028-2032 and wants patient groups, healthcare pros, and experts to join monthly meetings starting October 2025. These fees help fund faster medical device reviews, and the current law ends September 2027, so new rules are needed. If you’re involved, let the FDA know by July 28, 2025, to keep the conversation rolling and the devices improving!

## Abstract

The Food and Drug Administration (FDA or the Agency) is issuing this notice to request that public stakeholders--including patient and consumer advocacy groups, healthcare professionals, and scientific and academic experts--notify FDA of their intent to participate in periodic consultation meetings on the reauthorization of the Medical Device User Fee Amendments (MDUFA). The statutory authority for MDUFA expires September 30, 2027. At that time, new legislation will be required for FDA to continue collecting user fees for the medical device program. The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires that FDA consult with a range of stakeholders in developing recommendations for the next MDUFA program. The FD&C Act also requires that FDA hold discussions (at least every month) with patient and consumer advocacy groups during FDA's negotiations with the regulated industry. The purpose of this request for notification is to ensure continuity and progress in these monthly discussions by establishing consistent stakeholder representation.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-11911 on federalregister.gov](https://www.federalregister.gov/documents/2025/06/27/2025-11911/medical-device-user-fee-amendments-stakeholder-meetings-on-the-medical-device-user-fee-amendments-of)
- [2025-11911 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-06-27/pdf/2025-11911.pdf)

## Related
- [Previous: 2025-11910, Foreign-Trade Zone (FTZ) 49; Authorization of Production Activity; Merck, Sharp…](https://policyrisk.com/federal-register/2025-11910)
- [Next: 2025-11912, Polyester Textured Yarn From the People's Republic of China and India: Continua…](https://policyrisk.com/federal-register/2025-11912)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-11911 (as of 2026-11-05).
